$90.53
+2.76 (+3.14%)
At Close: Jun 23, 2026
Abbott (ABT) Surpasses Q1 Earnings and Revenue Estimates
12:45pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Abbott (ABT) delivered earnings and revenue surprises of 17.69% and 7.17%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Abbott predicts fewer sales of COVID-19 tests in 2022 but says the business of at-home tests isn't going away
12:25pm, Wednesday, 20'th Apr 2022
Abbott Laboratories, the maker of the popular rapid BinaxNow COVID-19 test, made $3.3 billion in revenue from its COVID-19 tests in the first three months of the year, far surpassing the $2.5 billion
Abbott Laboratories (ABT) CEO Robert Ford on Q1 2022 Results - Earnings Call Transcript
12:16pm, Wednesday, 20'th Apr 2022
Abbott Laboratories (NYSE:ABT ) Q1 2022 Earnings Conference Call April 20, 2022 9:00 AM ET Company Participants Scott Leinenweber - Vice President, Investor Relations, Licensing and Acquisition Robert
Abbott's (ABT) Q1 Earnings and Revenues Exceed Estimates
12:02pm, Wednesday, 20'th Apr 2022
Within Adult Nutrition, Abbott (ABT) gains from the strong performance of Ensure and Glucerna brands in Q1.
Highly Valued Abbot Laboratories Could Move Lower
10:37am, Wednesday, 20'th Apr 2022
Abbott Laboratories (NYSE: ABT) is not in danger of losing its business but we have some concerns its share price could fall. Not only is it a highly-valued stock compared to peers but its current rev
A Peek Into The Markets: US Stock Futures Flat Ahead Of Earnings; Netflix Shares Plunge
10:11am, Wednesday, 20'th Apr 2022 Benzinga
Pre-open movers
U.S. stock futures traded mostly flat in early pre-market trade after the Dow Jones jumped around 500 points in the previous session. Investors are awaiting earnings results from The
Abbott Clocks Q1 COVID-19 Test Sales Of $3.3B, Reaffirms FY22 EPS Outlook
09:28am, Wednesday, 20'th Apr 2022
Abbott Laboratories (NYSE: ABT) has reported Q1 FY22 adjusted EPS of $1.73, up 31.1% Y/Y, better than the consensus of $1.47 and the management guidance of $1.50. Q1 sales of $11.9 billion increased
5 Stocks To Watch For April 20, 2022
09:02am, Wednesday, 20'th Apr 2022 Benzinga
Some of the stocks that may grab investor focus today are:
Wall Street expects The Procter & Gamble Company (NYSE: PG) to report quarterly earnings at $1.30 per share on revenue of $18.73 billion be
Abbott reported $3.3 billion in sales of COVID-19 tests in the first quarter
08:00am, Wednesday, 20'th Apr 2022
Shares of Abbott Laboratories ABT, +3.17% were down 2.0% in premarket trading on Wednesday though the company beat earnings and revenue expectations in the first quarter of 2022, driven in large part
Abbott reports 36% rise in quarterly profit on Omicron-driven testing demand
07:40am, Wednesday, 20'th Apr 2022
Abbott Laboratories reported a 36% rise in quarterly profit on Wednesday, boosted by an Omicron-led demand for its COVID-19 test kits and a recovery in elective procedures, which boosted demand for it
Why Abbott (ABT) Could Beat Earnings Estimates Again
04:10pm, Tuesday, 19'th Apr 2022 Zacks Investment Research
Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Things About Abbott Laboratories That Smart Investors Know
02:45pm, Tuesday, 19'th Apr 2022 The Motley Fool
Abbott's innovation and execution drive long-term success despite many moving parts.
Why Abbott (ABT) Could Beat Earnings Estimates Again
01:33pm, Tuesday, 19'th Apr 2022
Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?
01:20pm, Monday, 18'th Apr 2022 Zacks Investment Research
Excluding COVID testing sales, Abbott's (ABT) worldwide Diagnostic sales are expected to have demonstrated strong growth in Q1 on the continuous rollout of Alinity, Abbott's suite of diagnostic instru
Earnings Previews: Abbott Labs, Baker Hughes, Procter & Gamble
12:18pm, Monday, 18'th Apr 2022
Before markets opened on Monday, Bank of America reported first-quarter results that beat both revenue and profit estimates, and shares traded up about 1%.
Sign In
Buy ABT